Barbara Banelli

Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients

Ida Casciano, Katia Mazzocco, Luca Boni et al. · Cell Death and Differentiation · 2002 · 177 citations

Medicine, Molecular Genetics, Oncology +5

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma

Barbara Banelli, Elisa Carra, Federica Barbieri et al. · Cell Cycle · 2015 · 128 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme

Davide Barbagallo, Angelo Giuseppe Condorelli, Marco Ragusa et al. · Oncotarget · 2015 · 121 citations · Full text

Medicine, Molecular Biology, Oncology +17

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

Maria Pia Pistillo, Vincenzo Fontana, Anna Morabito et al. · Cancer Immunology Immunotherapy · 2018 · 92 citations · Full text

Medicine, Immunology, Oncology +17

Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury

Giuseppe Castellano, Rossana Franzin, Fabio Sallustio et al. · Aging · 2019 · 92 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17